Shingo Ono

Significant pharmacokinetic interaction between risperidone and carbamazepine: its relationship with CYP2D6 genotypes

Shingo Ono, Kazuo Mihara, Akihito Suzuki et al. · Psychopharmacology · 2002 · 66 citations

Medicine, Pharmacokinetics, Pharmacology +12

Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndrome

Kazuo Mihara, Tsuyoshi Kondo, Akihito Suzuki et al. · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · 2002 · 63 citations

Life Sciences, Genetics, Psychiatry +11

Effects of Various CYP2D6 Genotypes on the Steady-State Plasma Concentrations of Risperidone and Its Active Metabolite, 9-Hydroxyrisperidone, in Japanese Patients With Schizophrenia

Kazuo Mihara, Tsuyoshi Kondo, Norio Yasui‐Furukori et al. · Therapeutic Drug Monitoring · 2003 · 59 citations

Medicine, Pharmacokinetics, Pharmacology +17

Prolactin response to nemonapride, a selective antagonist for D 2 like dopamine receptors, in schizophrenic patients in relation to Taq 1A polymorphism of DRD2 gene

Kazuo Mihara, Tsuyoshi Kondo, Akihito Suzuki et al. · Psychopharmacology · 2000 · 55 citations

Medicine, Pharmacology, Psychiatry +15

Relationship between <i>Taq</i>1 A dopamine D2 receptor (<i>DRD2</i>) polymorphism and prolactin response to bromperidol

Kazuo Mihara, Akihito Suzuki, Tsuyoshi Kondo et al. · American Journal of Medical Genetics · 2001 · 47 citations

Medicine, Pharmacology, Psychiatry +16